FDA: studies do not tie Chantix to mental problems
(AP) -- Federal health officials said Monday that Pfizer's anti-smoking drug Chantix did not increase psychiatric problems like depression and suicidal thoughts in two studies, though the findings are not definitive.
Oct 24, 2011
0
0